Literature DB >> 1358166

A comparison of membrane properties and composition between cell lines selected and transfected for multi-drug resistance.

R Callaghan1, L C van Gorkom, R M Epand.   

Abstract

Cell lines selected (CHRC5) and transfected (LR-73-1A) for multi-drug resistance have total lipid compositions which are indistinguishable between resistant and parental cells. Lipid composition was evaluated by 1H NMR and the total fatty acid content by GLC. No change in surface hydrophobicity, as measured with the fluorescent probe dansyl-PE, was observed as a result of transfection of CHO cells with the mdr1 gene. However, the selected cell line, CHRC5, showed a decreased surface hydrophobicity. This decreased surface hydrophobicity was indicated by an 8 nm increase in the fluorescence emission of dansyl-PE in the CHRC5 cell line compared with the AB1. Both resistant cell lines showed an increase in the polarisation of the fluorescent probe, TMA-DPH in the plasma membranes corresponding to a 14% and a 24% change in fluorescence polarisation for the selected and transfected cell lines, respectively. This is indicative of reduced mobility of the acyl chains in the resistant cell lines. Both the CHRC5 and the transfected cell lines showed almost a 2-fold increase in the initial rate of membrane cycling. The membrane cycling could be inhibited by a known bilayer stabiliser, the N-carbobenzoxy-D-Phe-L-Phe-Gly. These results indicate that the properties of the plasma membrane from resistant cells are altered compared with their parental cell line.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358166      PMCID: PMC1977978          DOI: 10.1038/bjc.1992.360

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  35 in total

1.  Internalization of the lipophilic fluorescent probe trimethylamino-diphenylhexatriene follows the endocytosis and recycling of the plasma membrane in cells.

Authors:  D Illinger; P Poindron; P Fonteneau; M Modollel; J G Kuhry
Journal:  Biochim Biophys Acta       Date:  1990-11-30

2.  Surface dielectric constant, surface hydrophobicity and membrane fusion.

Authors:  S Ohki; K Arnold
Journal:  J Membr Biol       Date:  1990-04       Impact factor: 1.843

3.  Characterization of lipid composition in stimulated human lymphocytes by 1H-NMR.

Authors:  D Y Sze; O Jardetzky
Journal:  Biochim Biophys Acta       Date:  1990-09-01

4.  Isolation and expression of a complementary DNA that confers multidrug resistance.

Authors:  P Gros; Y B Ben Neriah; J M Croop; D E Housman
Journal:  Nature       Date:  1986 Oct 23-29       Impact factor: 49.962

5.  Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: implications in drug-resistance phenomena.

Authors:  P V Escriba; A V Ferrer-Montiel; J A Ferragut; J M Gonzalez-Ros
Journal:  Biochemistry       Date:  1990-08-07       Impact factor: 3.162

6.  Differences in myristic acid synthesis and in metabolic rate for P388 cells resistant to doxorubicin.

Authors:  P J Wilder; D K Overman; T C Tenenholz; P L Gutierrez
Journal:  J Lipid Res       Date:  1990-11       Impact factor: 5.922

7.  Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection.

Authors:  K Choi; T O Frommel; R K Stern; C F Perez; M Kriegler; T Tsuruo; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

8.  Peptide inhibitors of enveloped virus infection inhibit phospholipid vesicle fusion and Sendai virus fusion with phospholipid vesicles.

Authors:  D R Kelsey; T D Flanagan; J Young; P L Yeagle
Journal:  J Biol Chem       Date:  1990-07-25       Impact factor: 5.157

9.  Hexagonal phase forming propensity detected in phospholipid bilayers with fluorescent probes.

Authors:  R M Epand; B T Leon
Journal:  Biochemistry       Date:  1992-02-11       Impact factor: 3.162

10.  Effects of viral chemotherapeutic agents on membrane properties. Studies of cyclosporin A, benzyloxycarbonyl-D-Phe-L-Phe-Gly and amantadine.

Authors:  R M Epand; R F Epand; R C McKenzie
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

View more
  12 in total

1.  Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.

Authors:  Andrew S Goldsborough; Misty D Handley; Andrés E Dulcey; Kristen M Pluchino; Pavitra Kannan; Kyle R Brimacombe; Matthew D Hall; Gary Griffiths; Michael M Gottesman
Journal:  J Med Chem       Date:  2011-06-24       Impact factor: 7.446

Review 2.  Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles.

Authors:  Chiranjeevi Peetla; Sivakumar Vijayaraghavalu; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2013-09-19       Impact factor: 15.470

Review 3.  Molecular analysis of the multidrug transporter.

Authors:  U A Germann
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

4.  Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator.

Authors:  J M Pérez-Victoria; F J Pérez-Victoria; A Parodi-Talice; I A Jiménez; A G Ravelo; S Castanys; F Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 5.  Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?

Authors:  Wing-Kee Lee; Richard N Kolesnick
Journal:  Cell Signal       Date:  2017-07-04       Impact factor: 4.315

Review 6.  Tumour fatty acid metabolism in the context of therapy resistance and obesity.

Authors:  Andrew J Hoy; Shilpa R Nagarajan; Lisa M Butler
Journal:  Nat Rev Cancer       Date:  2021-08-20       Impact factor: 60.716

7.  Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?

Authors:  M M Hoffman; L Y Wei; P D Roepe
Journal:  J Gen Physiol       Date:  1996-10       Impact factor: 4.086

Review 8.  Is resistance useless? Multidrug resistance and collateral sensitivity.

Authors:  Matthew D Hall; Misty D Handley; Michael M Gottesman
Journal:  Trends Pharmacol Sci       Date:  2009-09-15       Impact factor: 14.819

9.  Effects of dimethyl sulfoxide in cholesterol-containing lipid membranes: a comparative study of experiments in silico and with cells.

Authors:  Marie-Amélie de Ménorval; Lluis M Mir; M Laura Fernández; Ramon Reigada
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Arginine-based cationic liposomes for efficient in vitro plasmid DNA delivery with low cytotoxicity.

Authors:  Satya Ranjan Sarker; Yumiko Aoshima; Ryosuke Hokama; Takafumi Inoue; Keitaro Sou; Shinji Takeoka
Journal:  Int J Nanomedicine       Date:  2013-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.